New mRNA Cancer Vaccine: A Beacon of Hope for Brain Tumor PatientsResearch results have been released stating that a new mRNA vaccine has been developed that can trea ...
Double Trouble: Two APOE4 Genes Escalate Alzheimer's OnsetDBResearch has shown that people with two APOE4 genes have a higher risk of Alzheimer's disease.The ...
Eli Lilly's Alzheimer's Treatment Under Review by FDA Advisory CommitteeThe U.S. Food and Drug Administration (FDA) advisory committee will discuss Eli Lilly's Donanemab fo ...
Major Recall on Fluoxetine Capsules Over Potential Cancer RiskRecall of drugs containing nitrosamine impurities has led to a sanction of drugs made up of fluoxeti ...
Breakthrough Weight Loss Drug: Viking's VK2735 Shows Promise in Early TestsViking Therapeutics’ weight loss oral drug showed effectiveness in early-stage studies. Viking recently announced their weight loss oral drug VK2735 effectively reduced weight in a small-scale, early-stage study. Viking reported an average weight loss of 3.3% in just 28 days in seven subjects who took the maximum 40mg dosage of VK2735. In addition, Viking stated […]
New mRNA Cancer Vaccine: A Beacon of Hope for Brain Tumor Patients Research results have been released stating that a new mRNA vaccine has been developed that can trea ...
Double Trouble: Two APOE4 Genes Escalate Alzheimer's Onset DBResearch has shown that people with two APOE4 genes have a higher risk of Alzheimer's disease.The ...
Eli Lilly's Alzheimer's Treatment Under Review by FDA Advisory Committee The U.S. Food and Drug Administration (FDA) advisory committee will discuss Eli Lilly's Donanemab fo ...
Major Recall on Fluoxetine Capsules Over Potential Cancer Risk Recall of drugs containing nitrosamine impurities has led to a sanction of drugs made up of fluoxeti ...
Breakthrough Weight Loss Drug: Viking's VK2735 Shows Promise in Early Tests Viking Therapeutics’ weight loss oral drug showed effectiveness in early-stage studies. Viking recently announced their weight loss oral drug VK2735 effectively reduced weight in a small-scale, early-stage study. Viking reported an average weight loss of 3.3% in just 28 days in seven subjects who took the maximum 40mg dosage of VK2735. In addition, Viking stated […]
Hot Topics